Stay updated on Cabozantinib for CNS Tumors in Children Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.

Latest updates to the Cabozantinib for CNS Tumors in Children Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe clinical trial record is now displayed with details about the pediatric cabozantinib study, including its termination after failing to meet accrual goals, study design, eligibility requirements, and outcome measures.SummaryDifference50%

- Check14 days agoChange DetectedThe footer revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedA banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and points visitors to related updates and FAQs.SummaryDifference1%

- Check28 days agoChange DetectedThe 403 error page now displays site revision v3.7.2 instead of v3.7.1; the page content and error state remain unchanged.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check49 days agoChange DetectedRemoved the 403 Forbidden error block from the page, which would display an access denial message. This suggests the page may now render the normal study details content instead of an error placeholder.SummaryDifference0.5%

Stay in the know with updates to Cabozantinib for CNS Tumors in Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for CNS Tumors in Children Clinical Trial page.